 | • レポートコード：20QY06-05432 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、光線性角化症薬のグローバル市場について種類別（局所治療薬、光線力学療法薬、併用療法薬）、用途別（病院、クリニック、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・光線性角化症薬市場の概要 ・世界の主要地域別光線性角化症薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の光線性角化症薬市場規模2015-2026：種類別（局所治療薬、光線力学療法薬、併用療法薬） ・世界の光線性角化症薬市場規模2015-2026：用途別（病院、クリニック、その他） ・光線性角化症薬の北米市場規模2015-2020 ・光線性角化症薬のヨーロッパ市場規模2015-2020 ・光線性角化症薬の中国市場規模2015-2020 ・光線性角化症薬の日本市場規模2015-2020 ・光線性角化症薬の東南アジア市場規模2015-2020 ・光線性角化症薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Almirall、GALDERMA、LEO Pharma、Valeant、Biofrontera、Novartis、Perrigo、Promius Pharma、Taro Pharmaceutical Industries、TOLMAR Pharmaceuticals、Vidac Pharma） ・光線性角化症薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・光線性角化症薬の市場動向・機会・課題 ・調査の結論 |
Actinic keratosis or AK is a rough, scaly patch of skin that develops due to years of sun exposure. A small percentage of actinic keratosis spots can actually turn into skin cancer, Common places for actinic keratosis to develop include face, lips, ears, scalp, neck, backs of hands, and forearms.
The actinic keratosis drugs market includes nucleoside metabolic inhibitors, photosensitizers, nonsteroidal anti-inflammatory drugs (NSAIDs), and immunomodulators.
Market Analysis and Insights: Global Actinic Keratosis Drugs Market
The global Actinic Keratosis Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Actinic Keratosis Drugs Scope and Market Size
The global Actinic Keratosis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Actinic Keratosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Actinic Keratosis Drugs market is segmented into
Topical Treatment Drugs
Photodynamic Therapy Drugs
Combination Therapy Drugs
Segment by Application, the Actinic Keratosis Drugs market is segmented into
Hospitals
Clinics
Other
The Actinic Keratosis Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Actinic Keratosis Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Actinic Keratosis Drugs Market Share Analysis
Actinic Keratosis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Actinic Keratosis Drugs business, the date to enter into the Actinic Keratosis Drugs market, Actinic Keratosis Drugs product introduction, recent developments, etc.
The major vendors covered:
Almirall
GALDERMA
LEO Pharma
Valeant
Biofrontera
Novartis
Perrigo
Promius Pharma
Taro Pharmaceutical Industries
TOLMAR Pharmaceuticals
Vidac Pharma
Table of Contents
1 Actinic Keratosis Drugs Market Overview
1.1 Actinic Keratosis Drugs Product Scope
1.2 Actinic Keratosis Drugs Segment by Type
1.2.1 Global Actinic Keratosis Drugs Sales by Type (2020-2026)
1.2.2 Topical Treatment Drugs
1.2.3 Photodynamic Therapy Drugs
1.2.4 Combination Therapy Drugs
1.3 Actinic Keratosis Drugs Segment by Application
1.3.1 Global Actinic Keratosis Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Actinic Keratosis Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Actinic Keratosis Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Actinic Keratosis Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Actinic Keratosis Drugs Price Trends (2015-2026)
2 Actinic Keratosis Drugs Estimate and Forecast by Region
2.1 Global Actinic Keratosis Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Actinic Keratosis Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Actinic Keratosis Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Actinic Keratosis Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Actinic Keratosis Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Actinic Keratosis Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Actinic Keratosis Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Actinic Keratosis Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Actinic Keratosis Drugs Estimates and Projections (2015-2026)
2.4.3 China Actinic Keratosis Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Actinic Keratosis Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Actinic Keratosis Drugs Estimates and Projections (2015-2026)
2.4.6 India Actinic Keratosis Drugs Estimates and Projections (2015-2026)
3 Global Actinic Keratosis Drugs Competition Landscape by Players
3.1 Global Top Actinic Keratosis Drugs Players by Sales (2015-2020)
3.2 Global Top Actinic Keratosis Drugs Players by Revenue (2015-2020)
3.3 Global Actinic Keratosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic Keratosis Drugs as of 2019)
3.4 Global Actinic Keratosis Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Actinic Keratosis Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Actinic Keratosis Drugs Players (Opinion Leaders)
4 Global Actinic Keratosis Drugs Market Size by Type
4.1 Global Actinic Keratosis Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Actinic Keratosis Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Actinic Keratosis Drugs Price by Type (2014-2020)
4.2 Global Actinic Keratosis Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Actinic Keratosis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Actinic Keratosis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Actinic Keratosis Drugs Price Forecast by Type (2021-2026)
5 Global Actinic Keratosis Drugs Market Size by Application
5.1 Global Actinic Keratosis Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Actinic Keratosis Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Actinic Keratosis Drugs Price by Application (2015-2020)
5.2 Global Actinic Keratosis Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Actinic Keratosis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Actinic Keratosis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Actinic Keratosis Drugs Price Forecast by Application (2021-2026)
3 North America Actinic Keratosis Drugs Market Facts & Figures
3.2 North America Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
3.3 North America Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
3.4 North America Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
4 Europe Actinic Keratosis Drugs Market Facts & Figures
4.2 Europe Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
5 China Actinic Keratosis Drugs Market Facts & Figures
5.2 China Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
5.3 China Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
5.4 China Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
6 Japan Actinic Keratosis Drugs Market Facts & Figures
6.2 Japan Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Actinic Keratosis Drugs Market Facts & Figures
7.2 Southeast Asia Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
8 India Actinic Keratosis Drugs Market Facts & Figures
8.2 India Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
8.3 India Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
8.4 India Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Actinic Keratosis Drugs Business
12.1 Almirall
12.1.1 Almirall Actinic Keratosis Drugs Corporation Information
12.1.2 Almirall Actinic Keratosis Drugs Business Overview and Total Revenue
12.1.3 Almirall Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Almirall Actinic Keratosis Drugs Products Offered
12.1.5 Almirall Recent Development
12.2 GALDERMA
12.2.1 GALDERMA Actinic Keratosis Drugs Corporation Information
12.2.2 GALDERMA Actinic Keratosis Drugs Business Overview and Total Revenue
12.2.3 GALDERMA Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GALDERMA Actinic Keratosis Drugs Products Offered
12.2.5 GALDERMA Recent Development
12.3 LEO Pharma
12.3.1 LEO Pharma Actinic Keratosis Drugs Corporation Information
12.3.2 LEO Pharma Actinic Keratosis Drugs Business Overview and Total Revenue
12.3.3 LEO Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 LEO Pharma Actinic Keratosis Drugs Products Offered
12.3.5 LEO Pharma Recent Development
12.4 Valeant
12.4.1 Valeant Actinic Keratosis Drugs Corporation Information
12.4.2 Valeant Actinic Keratosis Drugs Business Overview and Total Revenue
12.4.3 Valeant Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Valeant Actinic Keratosis Drugs Products Offered
12.4.5 Valeant Recent Development
12.5 Biofrontera
12.5.1 Biofrontera Actinic Keratosis Drugs Corporation Information
12.5.2 Biofrontera Actinic Keratosis Drugs Business Overview and Total Revenue
12.5.3 Biofrontera Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Biofrontera Actinic Keratosis Drugs Products Offered
12.5.5 Biofrontera Recent Development
12.6 Novartis
12.6.1 Novartis Actinic Keratosis Drugs Corporation Information
12.6.2 Novartis Actinic Keratosis Drugs Business Overview and Total Revenue
12.6.3 Novartis Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Novartis Actinic Keratosis Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Perrigo
12.7.1 Perrigo Actinic Keratosis Drugs Corporation Information
12.7.2 Perrigo Actinic Keratosis Drugs Business Overview and Total Revenue
12.7.3 Perrigo Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Perrigo Actinic Keratosis Drugs Products Offered
12.7.5 Perrigo Recent Development
12.8 Promius Pharma
12.8.1 Promius Pharma Actinic Keratosis Drugs Corporation Information
12.8.2 Promius Pharma Actinic Keratosis Drugs Business Overview and Total Revenue
12.8.3 Promius Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Promius Pharma Actinic Keratosis Drugs Products Offered
12.8.5 Promius Pharma Recent Development
12.9 Taro Pharmaceutical Industries
12.9.1 Taro Pharmaceutical Industries Actinic Keratosis Drugs Corporation Information
12.9.2 Taro Pharmaceutical Industries Actinic Keratosis Drugs Business Overview and Total Revenue
12.9.3 Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Taro Pharmaceutical Industries Actinic Keratosis Drugs Products Offered
12.9.5 Taro Pharmaceutical Industries Recent Development
12.10 TOLMAR Pharmaceuticals
12.10.1 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Corporation Information
12.10.2 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Business Overview and Total Revenue
12.10.3 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 TOLMAR Pharmaceuticals Actinic Keratosis Drugs Products Offered
12.10.5 TOLMAR Pharmaceuticals Recent Development
12.11 Vidac Pharma
12.11.1 Vidac Pharma Actinic Keratosis Drugs Corporation Information
12.11.2 Vidac Pharma Actinic Keratosis Drugs Business Overview and Total Revenue
12.11.3 Vidac Pharma Actinic Keratosis Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Vidac Pharma Actinic Keratosis Drugs Products Offered
12.11.5 Vidac Pharma Recent Development
13 Actinic Keratosis Drugs Manufacturing Cost Analysis
13.1 Actinic Keratosis Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Actinic Keratosis Drugs
13.4 Actinic Keratosis Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Actinic Keratosis Drugs Distributors List
14.3 Actinic Keratosis Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Actinic Keratosis Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Actinic Keratosis Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Actinic Keratosis Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Actinic Keratosis Drugs Sales (K Units) by Region (2015-2020)
Table 5. Global Actinic Keratosis Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Actinic Keratosis Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Actinic Keratosis Drugs Revenue Share by Region (2015-2020)
Table 8. Global Actinic Keratosis Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Actinic Keratosis Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Actinic Keratosis Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Actinic Keratosis Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Actinic Keratosis Drugs (K Units) of Key Companies (2015-2020)
Table 13. Global Actinic Keratosis Drugs Sales Share by Company (2015-2020)
Table 14. Global Actinic Keratosis Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Actinic Keratosis Drugs Revenue Share by Company (2015-2020)
Table 16. Global Actinic Keratosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Actinic Keratosis Drugs as of 2019)
Table 17. Global Actinic Keratosis Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Actinic Keratosis Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Actinic Keratosis Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Actinic Keratosis Drugs Players
Table 22. Global Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 23. Global Actinic Keratosis Drugs Sales Share by Type (2015-2020)
Table 24. Global Actinic Keratosis Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Actinic Keratosis Drugs Price (K Units) by Type (2015-2020)
Table 26. Global Actinic Keratosis Drugs Sales Share by Type (2021-2026)
Table 27. Global Actinic Keratosis Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Actinic Keratosis Drugs Revenue Share by Type (2021-2026)
Table 29. Global Actinic Keratosis Drugs Price (K Units) by Type (2021-2026)
Table 30. Global Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 31. Global Actinic Keratosis Drugs Sales Share by Application (2015-2020)
Table 32. Global Actinic Keratosis Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Actinic Keratosis Drugs Price (K Units) by Application (2015-2020)
Table 34. Global Actinic Keratosis Drugs Sales (K Units) by Application (2021-2026)
Table 35. Global Actinic Keratosis Drugs Sales Share by Application (2021-2026)
Table 36. Global Actinic Keratosis Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Actinic Keratosis Drugs Revenue Share by Application (2021-2026)
Table 38. Global Actinic Keratosis Drugs Price (K Units) by Application (2021-2026)
Table 39. United States Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 40. United States Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 42. United States Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 44. United States Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 46. Europe Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 48. Europe Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 50. Europe Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 51. China Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 52. China Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 53. China Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 54. China Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 55. China Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 56. China Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 58. Japan Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 60. Japan Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 62. Japan Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
Table 69. India Actinic Keratosis Drugs Sales (K Units) by Company (2015-2020)
Table 70. India Actinic Keratosis Drugs Sales Market Share by Company (2015-2020)
Table 71. India Actinic Keratosis Drugs Sales (K Units) by Type (2015-2020)
Table 72. India Actinic Keratosis Drugs Sales Market Share by Type (2015-2020)
Table 73. India Actinic Keratosis Drugs Sales (K Units) by Application (2015-2020)
Table 74. India Actinic Keratosis Drugs Sales Market Share by Application (2015-2020)
Table 75. Almirall Corporation Information
Table 76. Almirall Description and Business Overview
Table 77. Almirall Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Almirall Actinic Keratosis Drugs Product
Table 79. Almirall Recent Development
Table 80. GALDERMA Corporation Information
Table 81. GALDERMA Description and Business Overview
Table 82. GALDERMA Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GALDERMA Actinic Keratosis Drugs Product
Table 84. GALDERMA Recent Development
Table 85. LEO Pharma Corporation Information
Table 86. LEO Pharma Description and Business Overview
Table 87. LEO Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. LEO Pharma Actinic Keratosis Drugs Product
Table 89. LEO Pharma Recent Development
Table 90. Valeant Corporation Information
Table 91. Valeant Description and Business Overview
Table 92. Valeant Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Valeant Actinic Keratosis Drugs Product
Table 94. Valeant Recent Development
Table 95. Biofrontera Corporation Information
Table 96. Biofrontera Description and Business Overview
Table 97. Biofrontera Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Biofrontera Actinic Keratosis Drugs Product
Table 99. Biofrontera Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis Actinic Keratosis Drugs Product
Table 104. Novartis Recent Development
Table 105. Perrigo Corporation Information
Table 106. Perrigo Description and Business Overview
Table 107. Perrigo Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Perrigo Actinic Keratosis Drugs Product
Table 109. Perrigo Recent Development
Table 110. Promius Pharma Corporation Information
Table 111. Promius Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Promius Pharma Description and Business Overview
Table 113. Promius Pharma Actinic Keratosis Drugs Product
Table 114. Promius Pharma Recent Development
Table 115. Taro Pharmaceutical Industries Corporation Information
Table 116. Taro Pharmaceutical Industries Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Taro Pharmaceutical Industries Description and Business Overview
Table 118. Taro Pharmaceutical Industries Actinic Keratosis Drugs Product
Table 119. Taro Pharmaceutical Industries Recent Development
Table 120. TOLMAR Pharmaceuticals Corporation Information
Table 121. TOLMAR Pharmaceuticals Description and Business Overview
Table 122. TOLMAR Pharmaceuticals Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. TOLMAR Pharmaceuticals Actinic Keratosis Drugs Product
Table 124. TOLMAR Pharmaceuticals Recent Development
Table 125. Vidac Pharma Corporation Information
Table 126. Vidac Pharma Description and Business Overview
Table 127. Vidac Pharma Actinic Keratosis Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Vidac Pharma Actinic Keratosis Drugs Product
Table 129. Vidac Pharma Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Actinic Keratosis Drugs Distributors List
Table 133. Actinic Keratosis Drugs Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Actinic Keratosis Drugs Product Picture
Figure 2. Global Actinic Keratosis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Actinic Keratosis Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Other Examples
Figure 9. Global Actinic Keratosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Actinic Keratosis Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Actinic Keratosis Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Actinic Keratosis Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Actinic Keratosis Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Actinic Keratosis Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Actinic Keratosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Actinic Keratosis Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Actinic Keratosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Actinic Keratosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Actinic Keratosis Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Actinic Keratosis Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Actinic Keratosis Drugs Players Market Share by Revenue in Actinic Keratosis Drugs 2015 & 2019
Figure 27. Actinic Keratosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Actinic Keratosis Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Actinic Keratosis Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Actinic Keratosis Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Actinic Keratosis Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 33. United States Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 34. Europe Actinic Keratosis Drugs Sales Market Share by Company in 2019
Figure 35. Europe Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 36. Europe Actinic Keratosis Drugs Sales Market Share by Application in 2019
Figure 37. China Actinic Keratosis Drugs Sales Market Share by Company in 2019
Figure 38. China Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 39. China Actinic Keratosis Drugs Sales Market Share by Application in 2019
Figure 40. Japan Actinic Keratosis Drugs Sales Market Share by Company in 2019
Figure 41. Japan Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 42. Japan Actinic Keratosis Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Actinic Keratosis Drugs Sales Market Share by Application in 2019
Figure 46. India Actinic Keratosis Drugs Sales Market Share by Company in 2019
Figure 47. India Actinic Keratosis Drugs Sales Market Share by Type in 2019
Figure 48. India Actinic Keratosis Drugs Sales Market Share by Application in 2019
Figure 49. Almirall Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GALDERMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. LEO Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Valeant Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Biofrontera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Perrigo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Promius Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Taro Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. TOLMAR Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Vidac Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Actinic Keratosis Drugs
Figure 62. Manufacturing Process Analysis of Actinic Keratosis Drugs
Figure 63. Actinic Keratosis Drugs Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
エクセナチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Exenatide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…- リラグルチド薬の世界市場レポート2020 A recently published report by QY Research titled Global Liraglutide Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- 泌尿生殖器薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Genitourinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genitourinary Drugs marke…
- 内分泌系薬の世界市場レポート2020 Market Analysis and Insights: Global Endocrine System Drugs Market The global Endocrine System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Endocrine System Drugs Scope and Market Size The global…
- 消化器系薬の世界市場レポート2020 Market Analysis and Insights: Global Digestive System Drugs Market The global Digestive System Drugs market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Digestive System Drugs Scope and Market Size The global…